NCT01378429View on ClinicalTrials.gov

Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Perennial Allergic RhinitisPAR
Interventions
DRUG

ciclesonide nasal aerosol

ciclesonide nasal aerosol (74 mcg)

DRUG

Placebo

Placebo

Trial Locations (7)

30281

Clinical Research Atlanta, Stockbridge

55441

Clinical Research Institute, Plymouth

61761

Sneeze, Wheeze, & Itch Associates, LLC, Normal

78130

Central Texas Health Research, New Braunfels

78229

Sylvania Research Associates, San Antonio

79903

Western Sky Medical Research, El Paso

92626

West Coast Clinical Trials, Costa Mesa

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY

NCT01378429 - Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis | Biotech Hunter | Biotech Hunter